Transcripts Resverlogix Corp. OTC Markets
Stocks
RVXCF
CA76128M1086
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0752 USD | +7.05% |
|
+2.73% | +1.35% |
| 06-25 | Resverlogix Corp. - Shareholder/Analyst Call | |
| 05-15 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Transcripts
Search
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
















